Nanalysis Scientific Corp. NSCIF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 7.02M | 7.78M | 7.66M | 6.74M | 6.92M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.02M | 7.78M | 7.66M | 6.74M | 6.92M |
| Cost of Revenue | 5.19M | 6.03M | 5.58M | 5.27M | 5.24M |
| Gross Profit | 1.83M | 1.75M | 2.08M | 1.47M | 1.68M |
| SG&A Expenses | 1.31M | 1.60M | 1.44M | 1.66M | 2.20M |
| Depreciation & Amortization | 602.50K | 616.00K | 367.30K | 602.60K | 713.40K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.23M | 8.41M | 7.43M | 7.59M | 8.25M |
| Operating Income | -211.00K | -637.90K | 223.80K | -850.90K | -1.33M |
| Income Before Tax | -497.80K | -905.40K | -534.40K | -1.08M | -1.56M |
| Income Tax Expenses | -16.60K | 28.40K | -11.50K | 11.60K | -24.60K |
| Earnings from Continuing Operations | -481.20K | -933.80K | -522.90K | -1.09M | -1.53M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -481.20K | -933.80K | -522.90K | -1.09M | -1.53M |
| EBIT | -211.00K | -637.90K | 223.80K | -850.90K | -1.33M |
| EBITDA | 432.00K | -529.20K | 332.80K | -753.60K | -571.00K |
| EPS Basic | 0.00 | -0.01 | 0.00 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| EPS Diluted | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 138.52M | 136.88M | 117.22M | 114.82M | 113.54M |
| Average Diluted Shares Outstanding | 138.52M | 136.88M | 117.22M | 114.82M | 113.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |